| 1 |
Effects of Share 35 Policy on Liver Transplantation Outcomes for Patients With Nonalcoholic Steatohepatitis.
38
|
Zhang Y...Boktour MR
|
31146627
|
2019 |
| 2 |
Non-alcoholic fatty liver disease after liver transplantation in patients with non-alcoholic steatohepatitis and cryptogenic cirrhosis: the impact of pre-transplant graft steatosis.
38
|
Eshraghian A...Malek-Hosseini SA
|
31431413
|
2019 |
| 3 |
Reduced lysosomal acid lipase activity: A new marker of liver disease severity across the clinical continuum of non-alcoholic fatty liver disease?
38
|
Baratta F...Del Ben M
|
31435171
|
2019 |
| 4 |
Lysosomal acid lipase activity and liver fibrosis in the clinical continuum of non-alcoholic fatty liver disease.
38
|
Baratta F...Del Ben M
|
31392821
|
2019 |
| 5 |
Cryptogenic cirrhosis: Old and new perspectives in the era of molecular and genomic medicine.
38
|
Nalbantoglu I...Jain D
|
31395291
|
2019 |
| 6 |
Cryptogenic liver cirrhosis and hepatitis E virus (HEV): Are they related?
38
|
Akyuz F...Kaymakoglu S
|
31130469
|
2019 |
| 7 |
Position statement on the diagnosis and management of non-alcoholic fatty liver disease.
38
|
Alswat KA...Al-Osaimi A
|
31219486
|
2019 |
| 8 |
Clinical course and mortality by etiology of liver cirrhosis in Sweden: a population based, long-term follow-up study of 1317 patients.
38
|
Nilsson E...Prytz H
|
30957910
|
2019 |
| 9 |
Metastatic cholangiocarcinoma in a patient with undiagnosed Wilson disease.
38
|
Mavilia MG...Forouhar F
|
31167735
|
2019 |
| 10 |
Predisposing Conditions to Pediatric Hepatocellular Carcinoma and Association With Outcomes: Single-center Experience.
38
|
Cowell E...Miloh T
|
30676520
|
2019 |
| 11 |
NASH Is the Most Rapidly Growing Etiology for Acute-on-Chronic Liver Failure-Related Hospitalization and Disease Burden in the United States: A Population-Based Study.
38
|
Axley P...Singal AK
|
30861321
|
2019 |
| 12 |
Outcome of Liver Transplant Patients With Intraoperative-Detected Portal Vein Thrombosis: A Retrospective Cohort Study in Shiraz, Iran.
38
|
Bagheri Lankarani K...Malekhosseini SA
|
30995894
|
2019 |
| 13 |
The Frequency of Lysosomal Acid Lipase Deficiency in Children With Unexplained Liver Disease.
38
|
Kuloglu Z...National LAL-D Study Group
|
30540705
|
2019 |
| 14 |
Evaluation of Underlying Liver Disease and Its Severity in Children Referred for Liver Transplant: a Single-Center Report From Nemazee Hospital of Shiraz.
38
|
Dehghani SM...Mardani S
|
30836904
|
2019 |
| 15 |
Fibrinolysis Shutdown Is Associated With Thrombotic and Hemorrhagic Complications and Poorer Outcomes After Liver Transplantation.
38
|
Nicolau-Raducu R...Raveh Y
|
30548128
|
2019 |
| 16 |
Complete Heart Block due to Octreotide Infusion in Patient with Cryptogenic Cirrhosis.
38
|
Icen YK...Koc M
|
30911266
|
2019 |
| 17 |
Senescent Hepatocytes in Decompensated Liver Show Reduced UPRMT and Its Key Player, CLPP, Attenuates Senescence In Vitro.
38
|
Sen B...Ramakrishna G
|
30878663
|
2019 |
| 18 |
Technical success and outcomes in pediatric patients undergoing transjugular intrahepatic portosystemic shunt placement: a 20-year experience.
38
|
Ghannam JS...Gemmete JJ
|
30291382
|
2019 |
| 19 |
Increasing Incidence of Nonalcoholic Steatohepatitis as an Indication for Liver Transplantation in Australia and New Zealand.
38
|
Calzadilla-Bertot L...Adams LA
|
30609187
|
2019 |
| 20 |
Waiting List Mortality and Transplant Rates for NASH Cirrhosis When Compared With Cryptogenic, Alcoholic, or AIH Cirrhosis.
38
|
Thuluvath PJ...Savva Y
|
29985186
|
2019 |
| 21 |
Lysosomal Acid Lipase: Can it be a New Non-Invasive Serum Biomarker of Cryptogenic Liver Fibrosis and Cirrhosis?
38
|
Gravito-Soares M...Tome L
|
31113613
|
2019 |
| 22 |
Poor Survival After Retransplantation in NASH Cirrhosis.
38
|
Thuluvath AJ...Savva Y
|
29470354
|
2019 |
| 23 |
Lysosomal Acid Lipase: Can it be a New Non-Invasive Serum Biomarker of Cryptogenic Liver Fibrosis and Cirrhosis?
38
|
Gravito-Soares M...Tome L
|
30596627
|
2018 |
| 24 |
A decompensated cryptogenic cirrhosis? No, a late liver histiocytosis!
38
|
Ouizeman DJ...Anty R
|
30077466
|
2018 |
| 25 |
The conundrum of cryptogenic cirrhosis: Adverse outcomes without treatment options.
38
|
Younossi Z...Goodman Z
|
30144554
|
2018 |
| 26 |
Nonalcoholic fatty liver disease is an increasing indication for liver transplantation in the Nordic countries.
38
|
Holmer M...Hagstrom H
|
29630771
|
2018 |
| 27 |
Significance of Occult Hepatitis C Virus Infection in Liver Transplant Patients With Cryptogenic Cirrhosis.
38
|
Yaghobi R...Moayedi J
|
30346262
|
2018 |
| 28 |
Reply to: "NASH-related and cryptogenic cirrhosis similarities extend beyond cirrhosis": Cryptogenic cirrhosis should not be equated with NASH cirrhosis based on UNOS data mining and Bayesian 'doctrine of chances'.
38
|
Thuluvath PJ...Savva Y
|
29983203
|
2018 |
| 29 |
NASH-related and cryptogenic cirrhosis similarities extend beyond cirrhosis.
38
|
Giannini EG...Marabotto E
|
30227919
|
2018 |
| 30 |
A changing etiologic scenario in liver transplantation for hepatocellular carcinoma in a multicenter cohort study from Latin America.
38
|
Pinero F...Latin American Liver Research, Education, Awareness Network (LALREAN)
|
29773419
|
2018 |
| 31 |
Clinical characteristics and outcomes of hepatocellular carcinoma: results from prospective study, from a tertiary referral center in 
Sri Lanka
38
|
Bulathsinhala BKS...Dassanayake A
|
30415518
|
2018 |
| 32 |
Pernicious anemia associated with cryptogenic cirrhosis: Two case reports and a literature review.
38
|
Yan X...Jin J
|
30278550
|
2018 |
| 33 |
Non-cirrhotic portal hypertension: an imaging review.
38
|
Rajesh S...Arora A
|
29564495
|
2018 |
| 34 |
Liver Transplantation (LT) for Cryptogenic Cirrhosis (CC) and Nonalcoholic Steatohepatitis (NASH) Cirrhosis: Data from the Scientific Registry of Transplant Recipients (SRTR): 1994 to 2016.
38
|
Golabi P...Younossi ZM
|
30075518
|
2018 |
| 35 |
Identification of rare diseases by screening a population selected on the basis of routine pathology results-the PATHFINDER project: lysosomal acid lipase/cholesteryl ester storage disease substudy.
38
|
Reynolds TM...PATHFINDER Project Collaboration group
|
29358478
|
2018 |
| 36 |
Case report of high-dose hydroxocobalamin in the treatment of vasoplegic syndrome during liver transplantation.
38
|
An SS...McEvoy MD
|
29573551
|
2018 |
| 37 |
Role of Glutathione S Transferase M1 and T1 Gene Polymorphism in Hepatitis B Related Liver Diseases and Cryptogenic Cirrhosis.
38
|
Kapahtia S...Kar P
|
29892180
|
2018 |
| 38 |
A growing hepatic mass in a cryptogenic cirrhosis patient.
38
|
Song JS...Moon WS
|
29050462
|
2018 |
| 39 |
Raised plasma levels of H2S and nitrate predict intrapulmonary vascular dilations: A preliminary report in patients with cryptogenic cirrhosis.
38
|
Bera C...Eapen CE
|
29984390
|
2018 |
| 40 |
Prevalence of celiac disease among pediatric patients with cryptogenic cirrhosis and effect of gluten-free-diet.
38
|
Joshi A...Khatri PC
|
29948993
|
2018 |
| 41 |
Telomere Length, Aggregates, and Capture in Cirrhosis.
38
|
Laish I...Kitay-Cohen Y
|
29761675
|
2018 |
| 42 |
Stratifying Mortality in a Model for End-Stage Liver Disease Waiting List: A Brazilian Single-Center Study.
38
|
Martino RB...D'Albuquerque LAC
|
29661431
|
2018 |
| 43 |
Liver Transplantation in Cryptogenic Cirrhosis: Outcome Comparisons Between NASH, Alcoholic, and AIH Cirrhosis.
38
|
Thuluvath PJ...Savva Y
|
29215462
|
2018 |
| 44 |
Well Preserved Renal Function in Children With Untreated Chronic Liver Disease.
38
|
Berg UB...Nemeth A
|
29240010
|
2018 |
| 45 |
Complete splenic embolization for the treatment of refractory ascites after liver transplantation.
38
|
Nutu OA...Jimenez Romero LC
|
29411988
|
2018 |
| 46 |
Follow-up Creatinine Level Is an Important Predictive Factor of In-hospital Mortality in Cirrhotic Patients with Spontaneous Bacterial Peritonitis.
38
|
Jun BG...Kim HS
|
29542304
|
2018 |
| 47 |
Liver Transplantation in Patients With Hepatocellular Carcinoma Outside the Milan Criteria After Downstaging: Is It Worth It?
38
|
Cascales-Campos P...Parrilla P
|
29579861
|
2018 |
| 48 |
Systematic review with meta-analysis: de novo non-alcoholic fatty liver disease in liver-transplanted patients.
38
|
Losurdo G...Di Leo A
|
29359341
|
2018 |
| 49 |
Is cryptogenic cirrhosis different from NASH cirrhosis?
38
|
Thuluvath PJ...Savva Y
|
29162389
|
2018 |
| 50 |
Efficacy and Safety of Anti-TNF-α Agents in Inflammatory Bowel Disease After Liver Transplant: A Case Series.
38
|
Olmedo-Martin RV...Jimenez-Perez M
|
29579869
|
2018 |
